What is Dingdang Health Technology Group Operating Cash Flow per Share?
Dingdang Health Technology Group's operating cash flow per share for the
six
months ended in Dec. 2023 was HK$-0.18.
Dingdang Health Technology Group's operating cash flow per share for the trailing twelve months (TTM) ended in Dec. 2023 was HK$-0.00.
During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 71.40% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.
The historical rank and industry rank for Dingdang Health Technology Group's Operating Cash Flow per Share or its related term are showing as below:
HKSE:09886'
s 3-Year OCF Growth Rate Range Over the Past 10 Years
Min: -12.7 Med: 29.35 Max: 71.4
Current: 71.4
During the past 6 years, Dingdang Health Technology Group's highest 3-Year average Operating Cash Flow per Share Growth Rate was 71.40% per year. The lowest was -12.70% per year. And the median was 29.35% per year.
HKSE:09886's 3-Year OCF Growth Rate is ranked better than 94.15% of 496
companies
in the Healthcare Providers & Services industry
Industry Median: 9.35
vs HKSE:09886: 71.40
Dingdang Health Technology Group Operating Cash Flow per Share Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Premium members only.
Dingdang Health Technology Group Operating Cash Flow per Share Chart
Competitive Comparison of Dingdang Health Technology Group's Operating Cash Flow per Share
For the Health Information Services subindustry, Dingdang Health Technology Group's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Dingdang Health Technology Group's Price-to-Operating-Cash-Flow Distribution in the Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Dingdang Health Technology Group's Price-to-Operating-Cash-Flow distribution charts can be found below:
* The bar in red indicates where Dingdang Health Technology Group's Price-to-Operating-Cash-Flow falls into.
Dingdang Health Technology Group Operating Cash Flow per Share Calculation
Operating Cash Flow per Share is the amount of Cash Flow from Operations per outstanding share of the company's stock.
Operating Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$-0.00
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Dingdang Health Technology Group Operating Cash Flow per Share Related Terms
Thank you for viewing the detailed overview of Dingdang Health Technology Group's Operating Cash Flow per Share provided by GuruFocus.com. Please click on the following links to see related term pages.
Dingdang Health Technology Group (HKSE:09886) Business Description
Dingdang Health Technology Group Ltd is an investment holding company and its subsidiaries are principally engaged in the provision of pharmaceutical and healthcare business in the PRC. It is transforming and reshaping China's healthcare industry by pioneering on-demand pharmaceutical retail and medical consultation, with online-to-offline solutions.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
HKSE:09886 has been successfully added to your 